DYN Competitors & Alternatives
Compare Dyne Therapeutics Inc with similar stocks in the same industry
Biotechnology
DYN
Main Stock$15.20
Tradestie Score
51
Market Cap
$1.78B
Analyst Upside
+136.8%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$23.20
|
$3.31B | - | 53 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$23.63
|
$3.09B | - | 47 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$29.94
|
$3.08B | - | 57 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$38.02
|
$3.02B | - | 60 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$67.38
|
$3.01B | - | 54 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.22
|
$2.89B | - | 53 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$33.62
|
$2.85B | - | 56 | Compare |
More DYN Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry